Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 302, pseudogene (RN7SL302P)

Target
RN7SL302P
Molecular classification
Pseudogene, Noncoding RNA fragment derivative, Other
01

Overview

RN7SL302P is a pseudogene derived from the 7SL RNA gene family. Pseudogenes are defective gene copies generated during genome evolution, lacking the ability to encode a functional product[2][1][6]. The 7SL RNA itself is an essential part of the signal recognition particle (SRP), which mediates cotranslational protein targeting to the endoplasmic reticulum; however, pseudogenes like RN7SL302P are typically non-functional genomic remnants. Several hundreds of 7SL RNA-like sequences exist in the human genome, with most representing pseudogenes that have arisen from reverse transcription and insertion back into the genome[1][6]. RN7SL302P is one of these, and its locus is not transcribed at detectible levels nor known to play any biological role[1][6][2]. RN7SL302P is a genomic pseudogene, not a functional therapeutic target, receptor, enzyme, transporter, or biomarker. Its only established relevance is as a genomic artifact from evolutionary history of RNA processing and retrotransposition[1][6][2].

Other names
RN7SL302PRNA, 7SL, cytoplasmic 302, pseudogene
02

Mechanism of action

None (no drug targets this pseudogene, no enzymatic or receptor activity)

03

Biological functions

None established; does not encode a functional product7SL RNA pseudogenes do not perform known biological functions but represent reverse transcribed or duplicated remnants from the functional 7SL RNA gene
04

Disease associations

None established for the pseudogene itselfThe functional 7SL RNA (not this pseudogene) is implicated in cell signaling, viral response, and cancer cell communication
05

Safety considerations

None (no relevance to therapeutic safety or drug development)
06

Interacting drugs

None known or relevant (no evidence RN7SL302P interacts with any drugs)
07

Biomarkers

None (not used clinically or experimentally as a biomarker)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 302, pseudogene (RN7SL302P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 302, pseudogene (RN7SL302P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call